JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
TRMK
Trustmark Corporation
TRMK has a slight edge over JPM overall, supported by stronger valuation.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
TRMK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
TRMK's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like TRMK.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
TRMK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $42.45 | -11% |
| Forward | 11x | $47.84 | — |
| Fair | 12x | $48.11 | +0.6% |
| Current | 12x | $47.84 | — |
| Expensive | 15x | $60.55 | +27% |
Historical ranges are pointers, not guarantees.
TRMK has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
TRMK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
TRMK has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over TRMK on earnings, with more consistent year-over-year improvement.
TRMK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.21 | +5.6% |
| Q3 2026 | $3.99 | +9.3% |
| Q2 2026 | $3.93 | +11% |
| Q1 2024 | $2.56 | +68% |
| Q4 2023 | $2.70 | +131% |
| Q3 2023 | $1.57 | -27% |
| Q2 2023 | $1.70 | -5% |
| Q1 2023 | $1.52 | -24% |
| Q4 2022 | $1.17 | -50% |
TRMK's earnings per share have climbed steadily: $3.99 over the past year, up 9.3% from the year before, and higher year over year for eight quarters in a row.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over TRMK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over TRMK on profitability, with a higher operating margin.
TRMK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $207.1M | +2.4% |
| Q2 2026 | $208.2M | +4.8% |
| Q1 2026 | $202.9M | +4.2% |
| Q4 2025 | $204.1M | +3.7% |
| Q3 2025 | $202.4M | +5.3% |
| Q1 2025 | $194.6M | +3.4% |
| Q4 2024 | $196.8M | +5.5% |
| Q3 2024 | $192.3M | +0.7% |
TRMK's revenue has grown year over year for eight quarters in a row: $207M last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -0.5 points |
| Q2 2026 | 37% | +2.7 points |
| Q1 2026 | 34% | 0 points |
| Q4 2025 | 35% | +1.7 points |
| Q3 2025 | 34% | +2 points |
| Q2 2025 | 35% | N/A |
| Q1 2025 | 34% | +7.3 points |
| Q4 2024 | 33% | +9.7 points |
TRMK's operating margin was 34% last quarter, about level with the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
TRMK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $135.1M | +115% |
| Q2 2026 | $49.5M | +43% |
| Q1 2026 | $20.6M | -74% |
| Q4 2025 | $54.1M | -43% |
| Q3 2025 | $62.7M | +22% |
| Q1 2025 | $80.6M | +$144.2M |
| Q4 2024 | $95.3M | +67% |
| Q3 2024 | $51.2M | -48% |
TRMK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
TRMK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -474K shares |
| 1 year | -3.8% | -2.3M shares |
| 3 years | -4.9% | -3M shares |
| 5 years | -8.2% | -5.2M shares |
| Available history | -10% | -6.5M shares |
TRMK has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $20.1M |
| Q2 2026 | $21.1M |
| Q1 2026 | $19.8M |
| Q4 2025 | $43M |
| Q3 2025 | $11M |
| Q2 2025 | $11M |
| Q1 2025 | $15M |
| Q4 2023 | — |
TRMK spent $104M buying back its own shares over the past year.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
TRMK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | 0.2x | Very low |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | -1.6x | Net Cash |
TRMK has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
TRMK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.1 | Neutral |
| Stochastic | 32.7 | Neutral |
TRMK's weekly RSI is 59 (neutral) and its Stochastic is 33 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
TRMK PE vs Financial Services Sector
| Metric | TRMK | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.9% below |
| PE % | 47 | 63 | 16 pts below |
TRMK has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
TRMK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $45.5 | 5.1% above |
| 20 week MA | $46.3 | 3.3% above |
| 50 week MA | $44.3 | 8.1% above |
| 100 week MA | $40.4 | 18% above |
| 200 week MA | $34.0 | 41% above |
TRMK has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
TRMK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.5 | $27.3 | -21% |
| 2021 | $27.3 | $32.1 | +17% |
| 2022 | $32.1 | $34.7 | +8.4% |
| 2023 | $34.7 | $27.9 | -20% |
| 2024 | $27.9 | $35.9 | +29% |
| 2025 | $35.9 | $40.1 | +12% |
| 2026 YTD | $40.1 | $47.8 | +19% |
TRMK has the edge over JPM on returns for 2026, with the stronger performance.